2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Pain
1
Neoplasms
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphedema
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leiomyoma
1
Keratosis, Actinic
1
Hodgkin Disease
1
Dermatitis, Contact
1
Dendritic Cell Sarcoma, Interdigitating
1
Chalazion
1
Carcinoma, Basal Cell
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Breast Cancer Lymphedema
1
Anemia, Refractory, with Excess of Blasts
1
Adenomyosis
1
Interventions
Conservative Treatment
3
tyramine-deoxysorbitol
2
Probiotics
2
Curettage
2
Triamcinolone Acetonide
1
Triamcinolone
1
Tetracycline
1
Sevoflurane
1
Loteprednol Etabonate
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chalazion
×
Triamcinolone
×
Clear all
NCT02025023
2020-02-06
CTS
University of Washington
Phase 3
Recruiting
120 enrolled